MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance of
common stock for pipe...
$2,400,000
Net cash provided by
(used in) financing...
$2,253,065
Canceled cashflow
$146,935
Net change in cash
$467,386
Canceled cashflow
$1,785,679
Payments of transactions
cost
$117,473
Purchase of treasury
stock
$29,462
Accrued liability -
related party
$9,606,666
Stock-based compensation
$618,974
Accounts payable -
related party
$550,346
Prepaid expenses and
other receivable
-$431,188
Change in fair value of
derivative liabilities
$38,189
Other payables and
accrued liabilities
$36,654
Net cash used in
operating activities
-$1,785,679
Canceled cashflow
$11,282,017
Net loss
-$13,063,512
Franchise tax payable
-$4,134
Income tax payables
-$50
Back
Back
Cash Flow
source: myfinsight.com
Estrella Immunopharma, Inc. (ESLAW)
Estrella Immunopharma, Inc. (ESLAW)